Chronic non communicable diseases
Conditions
Interventions
A Sri Lankan trained pharmacist will provide a clinical pharmacy service to the intervention group in addition to the standard clinical management.
The pharmacist will
• obtain a detailed drug hist
Sponsors
South Asian Clinical Toxicology Research Collaboration
Eligibility
Inclusion criteria
Inclusion criteria: • Patients admitted to the professorial medical unit in CNTH • Age over 12 years • Able to communicate in Sinhala or English • Diagnosed with, a non communicable chronic disease (cardiovascular diseases, diabetes mellitus, pneumonia, cirrhosis, bronchial asthma and chronic obstructive pulmonary disease, chronic kidney diseases, peptic ulcer disease).
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The impact of clinical pharmacist’s service on the safety, efficacy and appropriateness of all prescribed medicines for individual patients [ using Medication Appropriateness Index - MAI ] [During the hospital stay] The impact of clinical pharmacist’s service on patients’ adherence to the drug regimen (compliance) is assessed by using a structured questionnaire at the 6th day of discharge through over the phone [6 days post discharge] The impact of clinical pharmacist’s service on patient knowledge and understanding of their medication regimen in the post discharge period is assessed through over the phone by using a structured questionnaire [6 days post discharge] | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in adverse drug reactions occurring during hospital stay by active surveillance and ADR reporting by the clinical pharmacist [During hospital stay] | — |
Countries
Sri Lanka
Contacts
Public ContactProf Asita de Silva
Professor in Pharmacology
Outcome results
None listed